Evidence map›Paper›PMID 34122425›Full record

ArticleFrontiers in immunology2021

Innate Immune Reconstitution in Humanized Bone Marrow-Liver-Thymus (HuBLT) Mice Governs Adaptive Cellular Immune Function and Responses to HIV-1 Infection.

Wilfredo F Garcia-Beltran, Daniel T Claiborne, Colby R Maldini, Meredith Phelps, Vladimir Vrbanac, Marshall E Karpel, Katharine L Krupp, Karen A Power, Christian L Boutwell, Alejandro B Balazs and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 25 citations in OpenAlex.

  1. Renaissance of antiviral CD8Nature reviews. Immunology · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Wilfredo F Garcia-BeltranDepartment of Pathology, Massachusetts General Hospital, Boston, MA, United States.
Daniel T ClaiborneRagon Institute of MGH, MIT and Harvard, Massachusetts General Hospital, Cambridge, MA, United States.
Colby R MaldiniRagon Institute of MGH, MIT and Harvard, Massachusetts General Hospital, Cambridge, MA, United States.
Meredith PhelpsRagon Institute of MGH, MIT and Harvard, Massachusetts General Hospital, Cambridge, MA, United States.
Vladimir VrbanacHuman Immune System Mouse Program, Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, United States.
Marshall E KarpelRagon Institute of MGH, MIT and Harvard, Massachusetts General Hospital, Cambridge, MA, United States.
Katharine L KruppRagon Institute of MGH, MIT and Harvard, Massachusetts General Hospital, Cambridge, MA, United States.
Karen A PowerRagon Institute of MGH, MIT and Harvard, Massachusetts General Hospital, Cambridge, MA, United States.
Christian L BoutwellRagon Institute of MGH, MIT and Harvard, Massachusetts General Hospital, Cambridge, MA, United States.
Alejandro B BalazsRagon Institute of MGH, MIT and Harvard, Massachusetts General Hospital, Cambridge, MA, United States.
Andrew M TagerCenter for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Boston, MA, United States.
Marcus AltfeldLeibniz Institute for Experimental Virology, Hamburg, Germany.
Todd M AllenRagon Institute of MGH, MIT and Harvard, Massachusetts General Hospital, Cambridge, MA, United States.
Ragon Institute of MGH, MIT and Harvard · USMassachusetts General Hospital · USLeibniz Institute of Virology (LIV) · DE

Funding

Medical Scientist Training ProgramT32GM007753 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI WALENSKY, LOREN DAVID · 1985 to 2021
$50.0M
Vaccine Adjuvant/ Delivery Systems CoreP01AI104715 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI ALLEN, TODD M · 2013 to 2017
$12.3M
Preclinical development of gene-edited human hematopoietic stem cellsU19HL129903 · NHLBI · HARVARD UNIVERSITY · PI NOVAK, RODGER · 2015 to 2019
$11.5M
TRAINING IN TRANSPLANTATION BIOLOGYT32AI007529 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI MADSEN, JOREN C · 1998 to 2024
$6.4M
Engineering Humoral Immunity to Functionally Cure HIV InfectionDP2DA040254 · NIDA · MASSACHUSETTS GENERAL HOSPITAL · PI BALAZS, ALEJANDRO BENJAMIN · 2015 to 2015
$2.6M
Interrogating mechanisms of HIV pathogenesis in the humanized BLT mouse modelF32AI136750 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI CLAIBORNE, DANIEL THOMAS · 2018 to 2020
$198k
Identifying the ligand for the activating NK cell receptor KIR3DS1 and its protective role in HIV-1 disease progressionF31AI116366 · NIAID · HARVARD MEDICAL SCHOOL · PI GARCIA-BELTRAN, WILFREDO F · 2015 to 2018
$157k
NHLBI NIH HHS U19 HL129903NIAID NIH HHS F31 AI116366NIAID NIH HHS F32 AI136750NIAID NIH HHS P01 AI104715NIAID NIH HHS T32 AI007529NIDA NIH HHS DP2 DA040254NIGMS NIH HHS T32 GM007753
6 · The paper itself

Abstract

Humanized bone marrow-liver-thymus (HuBLT) mice are a revolutionary small-animal model that has facilitated the study of human immune function and human-restricted pathogens, including human immunodeficiency virus type 1 (HIV-1). These mice recapitulate many aspects of acute and chronic HIV-1 infection, but exhibit weak and variable T-cell responses when challenged with HIV-1, hindering our ability to confidently detect HIV-1-specific responses or vaccine effects. To identify the cause of this, we comprehensively analyzed T-cell development, diversity, and function in HuBLT mice. We found that virtually all HuBLT were well-reconstituted with T cells and had intact TCRβ sequence diversity, thymic development, and differentiation to memory and effector cells. However, there was poor CD4+ and CD8+ T-cell responsiveness to physiologic stimuli and decreased TH1 polarization that correlated with deficient reconstitution of innate immune cells, in particular monocytes. HIV-1 infection of HuBLT mice showed that mice with higher monocyte reconstitution exhibited greater CD8+ T cells responses and HIV-1 viral evolution within predicted HLA-restricted epitopes. Thus, T-cell responses to immune challenges are blunted in HuBLT mice due to a deficiency of innate immune cells, and future efforts to improve the model for HIV-1 immune response and vaccine studies need to be aimed at restoring innate immune reconstitution.

Indexed as

Immune ReconstitutionAnimalsBiological EvolutionCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesDisease Models, AnimalHIV-1HIV InfectionsHumansMiceMice, Inbred NODMice, SCIDViremiaBLTHIV-1HuBLThumanized miceinnate immunityT cells

Identifiers

PMID34122425
PMCPMC8189152
OpenAlexW3164243037

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.